Delivery Order SPE2DB24D2216-SPE2DB25FGPVZ
Award Date 9/22/25
Potential Completion Date 9/23/25
Potential Value $3.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $13,882.26 to AmerisourceBergen Drug Corp for the supply of Pulmozyme 1 mg/mL ampules (2.5 mL) on July 23, 2025, with an ultimate completion date of July 24, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a discrete delivery of this specialty...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Pulmozyme 1 mg/mL ampules (2.5 mL) at a ceiling value of $6,286.98. This firm fixed-price delivery order, with an ultimate completion date of July 24, 2025, was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor. The performance location is...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Pulmozyme 1 mg/ml ampul 2.5ml on September 12, 2025, with a ceiling value of $5,167.20 and firm fixed pricing. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of September 15, 2025. The award represents a continuation of AmerisourceBergen's significant role as a critical pharmaceutical supplier to federal military and veteran healthcare...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Pulmozyme 1 mg/ml ampules (2.5 ml units) with a ceiling value of $12,701.74. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 27, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $10,334.40 to AmerisourceBergen Drug Corp for the supply of Pulmozyme 1 mg/ml ampul 2.5ml, a pharmaceutical product used in respiratory care. This firm fixed-price delivery order, awarded on July 17, 2025, with an ultimate completion date of July 18, 2025, represents a competitively awarded contract with no set-aside designation. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a $11,346.15 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Pulmozyme 1 mg/ml ampuls in 2.5 ml units. The contract, with an ultimate completion date of September 15, 2025, carries no set-aside designation and represents a competitive award under AmerisourceBergen's existing federal pharmaceutical supply agreements. Performance will be executed from the contractor's Corporate Office location in...
- The Defense Logistics Agency awarded a delivery order valued at $7,786.32 to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Pulmozyme 1 mg/ml ampul 2.5ml, a pharmaceutical product for respiratory conditions. This is a firm fixed price delivery order with an ultimate completion date of September 15, 2025, and will be performed at the vendor's location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 20, 2025, for the supply of Pulmozyme 1 mg/mL ampul 2.5mL with a ceiling value of $4,280.40. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and is scheduled for ultimate completion on May 21, 2025. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,356.71 to AmerisourceBergen Drug Corp for Pulmozyme 1 mg/ml ampule 2.5ml pharmaceutical supplies. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of September 18, 2025, issued on September 17, 2025. The contract will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Pulmozyme 1 mg/ml ampul 2.5ml, a pharmaceutical product commonly used in cystic fibrosis treatment. This non-set-aside, firm fixed-price delivery order has a ceiling value of $16,287.62 and an ultimate completion date of August 29, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...